Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor
- 1 December 1988
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 23 (6) , 725???32-732
- https://doi.org/10.1097/00006123-198812000-00007
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: